We support hematologists and pathologists in the diagnosis and diagnosis of blood diseases with artificial intelligence-based peripheral smear test. Our innovative solution automates time-consuming and labor-intensive manual peripheral smear testing from start to finish. Thanks to the automatic peripheral smear test, which provides reliable and fast results at much lower costs, hematology laboratories become much more efficient and the workload of hematologists is significantly reduced.

The HEM-AI PBS100BA produces magnified digital images of the entire sample with a report of the number of cells in the blood sample and their morphological abnormalities. Based on these results and pictures, hematologist and other specialist physicians can easily follow the diagnosis of the disease and the patient's response to the treatment applied.

CE certified HEM-AI PBS100BA significantly reduces the workload of lab technicians and specialist doctors. In the increasing time period, specialists will be able to serve more patients, and moreover, they will be able to focus more on the problems of the patients with the disease.

Health institutions, on the other hand, will provide faster service to their patients by automating the peripheral smear test, as well as gain a significant workforce gain and significantly reduce their costs. With the use of HEM-AI PBS100BA, costly different tests and unnecessary referrals will be avoided, especially in healthcare institutions where peripheral smear testing cannot be performed or takes a long time to do. In this way, both the early diagnosis of the health problems of the patients will be ensured and the workload of high-level health institutions will be alleviated.

According to the data obtained from currently examining around 15000 blood sample pictures, the success rates of the HEM-AI PBS100BA are as follows:

– White blood cells (Neutrophil, Lymphocyte, etc.): 97%

– Red blood cells (Macrocyte, Microcyte etc.): 98%

– Platelet (Aggregation, large etc.): 99%

Thanks to this feature of the HEM-AI PBS100BA, which is based on artificial intelligence using deep learning techniques, the success level is constantly increasing as the number of peripheral smear tests increases and the inputs of specialist doctors are also evaluated. That is, the HEM-AI PBS100BA with artificial intelligence is not static like other medical devices, but is constantly improving itself.